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Abstract
Background: Autosomal recessive defects of either the B1, E1, M1 or S1 subunit of the Adaptor Protein complex-4
(AP4) are characterized by developmental delay, severe intellectual disability, spasticity, and occasionally mild to
moderate microcephaly of essentially postnatal onset.
Case presentation: We report on a patient with severe microcephaly of prenatal onset, and progressive spasticity,
developmental delay, and severe intellectual deficiency. Exome sequencing showed a homozygous mutation in
AP4M1, causing the replacement of an arginine by a stop codon at position 338 of the protein (p.Arg338X). The
premature stop codon truncates the Mu homology domain of AP4M1, with predicted loss of function. Exome
analysis also showed heterozygous variants in three genes, ATR, MCPH1 and BLM, which are known causes of
autosomal recessive primary microcephaly.
Conclusions: Our findings expand the AP4M1 phenotype to severe microcephaly of prenatal onset, and more
generally suggest that the AP4 defect might share mechanisms of prenatal neuronal depletion with other genetic
defects of brain development causing congenital, primary microcephaly.
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Background
Primary microcephalies are a rare, genetically and
clinically heterogeneous group of disorders that result
from insufficient production of mature neurons
during neurogenesis. Known causal genes, e.g. ASPM
or CEP152, are involved in cell cycle control (DNA
integrity check, DNA replication, centrosome duplica-
tion and spindle pole organization). Alterations of
these processes may lead to isolated primary micro-
cephaly (MicroCephaly Primary Hereditary, MCPH)
or primary microcephaly with dwarfism (Seckel,
MOPD2 and Meier-Gorlin syndromes) [1, 2]. In line
with being caused by insufficient production of
mature neurons before birth, and contrary to second-
ary microcephalies, primary microcephalies typically
have a prenatal onset and present with a congenitally
small brain, progressing after the first year of life to a
fronto-occipital circumference smaller than 3 standard
deviations below the mean for age and sex [3].
AP4M1 is a component of the Adaptor Protein
Complex-4 (AP4). Homozygous mutations in AP4M1
have been associated with severe intellectual disability,
progressive spastic paraplegia, and inability to walk, in
six unrelated families [4–7]. The AP4M1 defect shares
these features with the defects of the other components
of the heterotetrameric AP4 complex, namely AP4B1,
E1 and S1, which have further been associated with
short stature and, inconsistently, with microcephaly.
Short stature and severe congenital microcephaly have
however not been reported with AP4M1 mutation.
We here report on a patient with an AP4M1 mutation,
short stature, and severe, congenital microcephaly that
initially mimicked MCPH.
Case presentation
The patient was a male infant, first born after a 37 weeks
gestation to second-cousin, asymptomatic parents of
Turkish origin. Both parents had unremarkable medical
histories, a normal head size and a normal intellect.
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They reported no paresis, and showed no spasticity nor
hyperreflexia. The pregnancy was unremarkable, with no
report of alcohol use or substance abuse, nor infection.
Severe microcephaly was noted at birth, with a head
circumference (HC) of 29 cm (−4.3SD), a length of
45 cm and a weight of 2.31 kg. Microcephaly progressed,
with a HC of 41.5 cm at 1.1 year (−4.1SD), 43 cm at 3yo
(−4.5SD), and 44 cm at 5.2 years (−4.7SD). The patient
also had short stature, with a length at −3.5SD and a
weight at −2.6SD. No dysmorphia was present except for
clinodactily of the fifth fingers. Global hypotonia was
present in the first months of life. Hypertonia was first
noted at age 9 months, and progressed, with a bilateral
Babinski sign. Partial complex epilepsy appeared at age
2 years and was treated successfully with valproate and
lamotrigine. Motor development was severely impaired.
The patient sat without support at age 1 year, crawled at
2 years, and stood with support at age 2.5 years. He
walked with support after age 3 years. He had mild
clubfeet deformities with flattened arches. Intellectual
development was severely impaired. Testing at the age of
4 months revealed a developmental stage corresponding
to the age of 3 months, and at the age of 9.5 months
corresponding to 5 months (Bayley scales of infant and
toddler development second edition). At the age of 8 years
he had no words, but showed emotions. MRI at age 2y8m
showed a normal cortex, temporo-parietal subcortical
atrophy and hippocampal atrophy bilaterally, enlarged
lateral ventricles, a thin corpus callosum predominantly in
its caudal portion, a normal cerebellum and a normal
white matter in FLAIR sequence acquisition (Fig. 1). A
standard karyotype was normal 46,XY. Plasma amino
acids and urine organic acids chromatograms showed
normal patterns. The parents divorced and the mother
had two other healthy children with a new partner.
After paediatric neurology evaluation and follow up,
the patient was referred to the genetics clinic for testing
of primary microcephaly genes. In a first round of
analysis, we used a 250 K SNP GeneChip® microarray
(AffymetrixTM, Inc.) and found heterozygosity of alleles
at loci MCPH1,2,3,4,5,7 and 9, making the correspond-
ing genes unlikely to cause microcephaly in the proband.
Direct sequencing of the coding exons and exon-intron
junctions of genes ASPM and WDR62 showed no
abnormality.
For whole-exome sequencing, the proband’s genomic
DNA was sheared and exonic sequences enriched using
Roche SeqCap EZ Human Exome v3.0 (64 Mb) DNA
capture. Sequencing was performed on a HiSeq1500
Illumina sequencer at the BRIGHTcore BRussels
Interuniversity Genomics High Throughput core [8].
Raw sequences were aligned to the reference genome
GRCh37 using BWA algorithm version 0.7.10 [9], dupli-
cated reads were then marked using Picard version 1.97
[10], alignment quality was improved using the GATK
[11] realigner and base recalibrator version 2.7, and
finally, variants were called using GATK Haplotype
Caller version 2.7. The resulting variant set was anno-
tated and filtered using the Highlander software [12].
Variants were filtered for quality criteria (pass GATK
standard filter, read depth > 5, variant confidence by
depth ≥ 10), allelic frequency < 0.5% (based on the
maximum minor allele frequency found in ExAC,
1000G, ESP6500, gonl, ARIC5606 and our in-house
database), nonsynonymous or splice junction effect in
protein coding genes (using biotype from Ensembl [13]
and snpeff_effect from SnpEff [14]) and genotype
(homozygous or heterozygous variants in a subset of 68
primary microcephaly genes that we extracted from the
literature (Additional file 1), and homozygous or biallelic
Fig. 1 Brain MRI of the proband at age 2 years and 8 months. Note the normal cortex, temporo-parietal subcortical atrophy bilaterally, enlarged
lateral ventricles, the thin corpus callosum predominantly in its caudal portion (arrow)
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variants from all other genes of the exome). Variants
were then sorted by decreasing Combined Annotation
Dependent Depletion (CADD) score [15]. A CADD
score between 0 and 10 is associated with non-
deleterious variants, and scores greater or equal to 20
are associated with the 1% most deleterious substitutions
possible. The variant of interest was confirmed by
Sanger sequencing of exon 13 of AP4M1. DNA was
amplified using a standard Polymerase Chain Reaction
(forward primer: AGTACAGCCCACACCCACAC, re-
verse primer: CACCTTCTTGAGGCAGACCC). The
PCR product was purified with Exosap-IT (Affymetrix),
and sequenced by the company Beckman Coulter
Genomics.
The affected child’s exome sequence data were first
analyzed for rare (allele frequency <0.5%) variants in 68
primary microcephaly-related genes. This showed
heterozygous missense variants in three genes: ATR
(c.6109A > G p.Met1996Thr), MCPH1 (c.85C > T
p.Ala3Ala) and BLM (c.3967G > A p.Gln1283Gln).
Analysis of the rest of the exome data revealed 5
hemizygous, 9 compound heterozygous, and 26 homozy-
gous variants, two of which being encompassed by a
9 Mb homozygous stretch (chr7: 91599825–100494222),
consistent with homozygosity by descent (autozygosity)
for this chromosomal segment. One of these three
variants, located at Chr7:99,703,901, consisted of a homo-
zygous truncating mutation in exon 13 of the AP4M1
gene, c.1170C > T (transcript_uniprot_id O00189) chan-
ging the Arginine at position 338 of the polypeptide into a
stop codon, p.Arg338X (Fig. 2). The variant frequency was
3.31×10^(−5) in the Exome Aggregation Consortium [16]
with only four alleles reported, all heterozygous, in 1
Latino and 3 European subjects. The variant was absent
from 1000G, GoNL, ESP, and our in-house database. The
mutation was located in the middle of the predicted Mu
homology domain of AP4M1 which spans amino acid
residues 176 through 453 (Fig. 2, left panel). Sanger
sequencing confirmed homozygosity of the mutation in
the proband and heterozygosity in both parents, as shown
in Fig. 2 right panel (father not shown). Among all
variants observed in the patient, this was the only variant
predicted to cause a premature termination codon. It
yielded a CADD score = 39, the highest of all observed
variants.
Discussion and conclusions
We investigated a child initially referred for primary
microcephaly of prenatal onset. Exome sequencing
revealed only one rare (MAF < 0.5%) variant predicted to
A
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Fig. 2 AP4M1 mutation and domains. a Exome sequencing data from proband, showing the filtering parameters used to sort through the variant
dataset. b Sanger sequencing of part of exon 13 of the AP4M1 gene, forward (left) and reverse (right). The C to T mutation (*) at position 1170 of
the coding DNA sequence was found homozygous in the proband (P), and heterozygous in his mother (M); a normal sequence is shown in an
unrelated control subject (C). c Linear presentation of the AP4M1 protein, showing the Longin-like domain (residues 1–141) and Mu homology
domain (residues 176–453). Arrow, position of the Arg338X mutation. d Crystal structure (PDB 3 l81 [27]) of AP4M1 C-terminal domain
(residues 160–453). The portion of the protein truncated by the mutation appears in red
Duerinckx et al. BMC Medical Genetics  (2017) 18:48 Page 3 of 5
introduce a premature termination codon. This
mutation was located in exon 13 of gene AP4M1 which
has 15 exons, and caused the replacement of an arginine
by a stop codon at position 338 (p.Arg338X). It is
predicted to truncate 41% of the predicted Mu
homology domain of the AP4M1 protein. This domain
is an important protein-protein interaction module
found in proteins involved in endocytosis. It has been
shown to interact with the cytosolic tail of transmem-
brane cargo proteins, through binding to tyrosine-based
signals [17–20]. Either this truncation, or nonsense-
mediated decay of the entire mRNA, is very likely to
cause complete loss of AP4M1 function in the proband.
AP complexes are important for vesicular trafficking
from the trans-golgi network to the plasma membrane
[21], with specificity of the AP complexes in selection of
the vesicles trafficked to or from the membrane and
inclusion of molecules to be cargoed in the vesicle [22].
AP4B1, E1 and S1 are, like M1, subunits of the AP4
complex, a heterotetramer. Defects of any of the four
subunits have been found in patients with autosomal
recessive intellectual disability and progressive spastic
paraplegia. These features were present in the proband,
providing further evidence for the causality of the
Arg338X mutation.
The proband presented with microcephaly of prenatal
onset and developed a short stature, features which have
not been reported in other patients with AP4M1
mutations, including homozygous truncating mutations,
making a more severe functional effect of the mutation
in the present proband unlikely to explain the more
severe phenotype. Interestingly, exome analysis also
showed heterozygous variants in three genes, ATR,
MCPH1 and BLM, which are known causes of
autosomal recessive primary microcephaly, presumably
via their role in DNA damage repair [23], homozygous
mutation of either of these genes causing increased
apoptosis of neural progenitors [24]. IER3IP1 is another
gene whose defect causes microcephaly via increased
apoptosis of neural progenitors [25]. It encodes a small
polypeptide localized at the ER and Golgi which, like the
AP4M1 product, plays a role in vesicle trafficking. It is
thus tempting to speculate that the additional heterozy-
gous variants in MCPH1, ATR and BLM, together modi-
fied the effect of the homozygous AP4M1 mutation,
causing increased apoptosis of neural progenitors, and
perhaps of other cell types. Of note, our patient also had
short stature, a feature reported with homozygous
mutations of either MCPH1, ATR, or BLM ([23] and
references therein).
Additional file 2 provides a compilation of clinical
features in all reported cases of AP4 defects and in the
present proband. While postnatal microcephaly, mild to
moderate (−1SD to −4 SD) has been reported in patients
with AP4B1, E1 and S1, all had normal head circumfer-
ences at birth, except one sibship (family ID01) where
microcephaly was reported as present since birth albeit
with no measures reported [26]. In addition, severe
microcephaly (<−4SD), and, more importantly, of
prenatal onset, has not been reported with AP4M1
mutations.
Our findings associate the AP4M1 mutation with
severe microcephaly of prenatal onset and short stature,
and suggest increased apoptosis as a likely mechanism.
This is important for the genetic diagnosis of congenital
microcephaly using massive parallel sequencing of multi-
gene panels, or clinical exomes. More generally, our
findings suggest that the AP4 mutation-related micro-
cephaly shares mechanisms of prenatal neural progenitor
depletion with other causes of congenital, primary
microcephaly.
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